Des de l'@idibell_cat us desitgem unes bones festes 🎉 i un 2025 ple de creativitat, curiositat i generositat🎄❤️🥂
At @idibell_cat, we wish you a Merry Christmas 🎉 and a 2025 full of creativity, curiosity and generosity⭐️💚🎊
📷Astrocit humà/Human astrocyte
Applications are open for the PhD program @IITalk with @semm_it Several positions available
Key dates:
CALL CLOSING 12 September 2024
EXAMINATION DAYS 23-26 September 2024
OFFICIAL STARTING DATE 1 November 2024
https://t.co/aaUticnqKG
pls RT
¿Podría el 💉tocilizumab frenar la evolución del Parkinson? Así lo sugieren investigadores del @idibell_cat e @IBUB_UB.
Te lo cuenta @carmenfefe.
https://t.co/m5xPiUmGZ1
#RecercaUB | 🧠 Un estudi sobre #Parkinson, liderat per @ConsiglioLab, ha identificat unes cèl·lules cerebrals que ataquen i eliminen les cèl·lules nervioses que produeixen la dopamina, un neurotransmissor que controla el moviment voluntari i és clau en aquesta patologia.
«Si poguéssim trobar la forma correcta de modular el sistema immunològic, podríem alentir el procés de la malaltia», afirma A. Consiglio.
👉https://t.co/PZnLeQSJzM
Our paper is finally out! We found that inflammed astrocytes induce neuronal degeneration in Parkinson’s disease through IL6. Great team work!!
@ConsiglioLab@idibell_cat@UniBarcelona
#Cover: Blocking IL-6 signaling prevents astrocyte-induced #neurodegeneration in an iPSC-based model of Parkinson’s disease: https://t.co/dQLBoWnu5p
Image: PD astrocytes releasing IL-6 (red), which binds to specific receptors on target cells (neurons); credit: @Ella_Maru
Descubren la eficacia de un fármaco contra la artritis reumatoide para frenar al párkinson.
Consigue bloquear los astrocitos, unas células cerebrales clave en el desarrollo de la enfermedad https://t.co/gcxom8WBVe
Identifiquen un fàrmac modulador del sistema immune potencialment útil per bloquejar la malaltia del @Parkinson
➡️ Més info: https://t.co/k8V1xJEdfM
Per @ConsiglioLab a @JCI_insight
Researchers led by @ConsiglioLab identify an immunomodulatory drug as a potential treatment for #Parkinson’s disease.
More info ➡️ https://t.co/MygU91Zpgo
Findings published at @JCI_insight.
New research reports that blocking IL-6 signaling (with Tocilizumab) prevents astrocyte-induced neurodegeneration in an iPSC-based model of #Parkinsons; IL-6/IL-6R signaling is increased in the SNc in postmortem brains at early stages of PD
https://t.co/MecaQpuZMW
#Cover: Blocking IL-6 signaling prevents astrocyte-induced #neurodegeneration in an iPSC-based model of Parkinson’s disease: https://t.co/dQLBoWnu5p
Image: PD astrocytes releasing IL-6 (red), which binds to specific receptors on target cells (neurons); credit: @Ella_Maru
Amazing story on the role of astrocytes in the occurrence of Parkinson’s disease! Congratulations @txell_pons and @ConsiglioLab ! Proud to be part of team ☺️
La Meritxell Pons @txell_pons, investigadora en malalties neurodegeneratives @idibell_cat, explica com podem millorar la memòria.
Si voleu continuar aprenent sobre refranys i salut, no us perdeu els nous reptes #curatensalut al setembre!
@veri_fi_cat
@fundaciorecerca @eduxarxa
🆕@idibell_cat@IRSJD_info@UniBarcelona creen un model basat en cèl·lules mare d'una malaltia causant de parkinsonisme infantil
Aquesta eina permetria desentrellar els mecanismes patogènics i implantar teràpies personalitzades
#IDIBELLnews#Parkinsons
➡️https://t.co/86U5bN8VgI
🆕@idibell_cat@IRSJD_info@UniBarcelona crean un modelo basado en células madre de una enfermedad causante de parkinsonismo infantil
Esta herramienta permitiría desentrañar los mecanismos patogénicos e implantar terapias personalizadas
#IDIBELLnews
➡️https://t.co/Y9ZHNoZxMg